Conventional and ambulatory blood pressure and menopause in a prospective population study

Journal of Human Hypertension

Volumn 11, Issue 8, 1997, Pages 507-514

  Staessen, J A ^a,b   Ginocchio, G ^a   Thijs, L ^a   Fagard, R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Blood pressure; Hypertension; Menopause

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; AGED; AGING; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE MONITORING; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; MENSTRUATION; POPULATION RESEARCH; POSTMENOPAUSE; PREMENOPAUSE; QUESTIONNAIRE; SPHYGMOMANOMETRY; STATISTICAL ANALYSIS; SYSTOLIC BLOOD PRESSURE;

EID: 0030846110     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1000476     Document Type: Article

References (35)

1. Staessen J, Amery A, Fagard R. Editorial review. Isolated systolic hypertension in the elderly. J Hypertens 1990; 8: 393-405.
2. Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: the Framingham study. Am J Epidemiol 1976; 103: 304-311.
3. Lindquist O. Intraindividual changes of blood pressure, serum lipids, and body weight in relation to menstrual status: results from a prospective population study of women in Göteborg, Sweden. Prev Med 1982; 11: 162-172.
4. van Beresteyn ECH, Van't Hof MA, De Waard H. Contributions of ovarian failure and aging to blood pressure in normotensive perimenopausal women: a mixed longitudinal study. Am J Epidemiol 1989; 129: 947-955.
5. van Beresteijn ECH et al. Habitual dietary calcium intake and blood pressure change around the menopause: a longitudinal study. Int J Epidemiol 1992; 21: 683-689.
6. The Writing Group for the PEPI Trial: Effects of estrogen or estrogen/progestin regimens of heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995; 273: 199-208.
7. Casiglia E at al. Lack of influence of menopause on blood pressure and cardiovascular risk profile: a 16-year longitudinal study concerning a cohort of 568 women. J Hypertens 1996; 14: 729-736.
8. Eferakeya AE, Imasuen JE. Relationship of menopause to serum cholesterol and arterial blood pressure in some Nigerian women. Public Health 1986; 100: 28-32.
9. Staessen J et al. The influence of menopause on blood pressure. J Hum Hypertens 1989; 3: 427-433.
10. Weiss NS. Relationship of menopause to serum cholesterol and arterial blood pressure: the United States Health Examination Survey of Adults. Am J Epidemiol 1972; 96: 237-241.
11. Lindquist O, Bengtsson C. Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Göteborg, Sweden. Scand J Clin Lab Invest 1980; 40: 629-636.
12. Wu Z, Wu X, Zhang Y. Relationship of menopausal status and sex hormones to serum lipids and blood pressure. Int J Epidemiol 1990; 19: 297-302.
13. Shibata H, Matsuzaki T, Hatano S. Relationship of relevant factors of atherosclerosis to menopause in Japanese women. Am J Epidemiol 1979; 109: 420-424,
14. Portaluppi F, Pansini F, Manfredi R, Mollica G. Relative influence of menopausal status, age, and body mass index on blood pressure. Hypertension 1997; 29: 976-979.
15. Richardson SJ, Nelson JF. Follicular depletion during the menopausal transition. Ann NY Acad Sci 1990; 592: 13-20.
16. Staessen JA et al. Renal function and historical environmental cadmium pollution from zinc smelters. Lancet 1994; 343: 1523-1527.
17. Staessen JA, Bieniaszewski L, Brosens I, Fagard R. The epidemiology of menopause and its association with cardiovascular disease. In: Messerli FH, Aepfelbacher FC (eds). Hypertension in Postmenopausal Women. Marcel Dekkers Inc: New York, NY, USA, 1996. pp 43-78.
18. O'Brien E, Mee F, Atkins N, O'Malley K. Evaluation of the SpaceLabs 90202 non-invasive ambulatory recorder according to the AAMI Standard and BHS criteria. J Hum Hypertens 1991; 5: 223-226.
19. Staessen JA et al. An epidemiologinal approach to ambulatory blood pressure monitoring: the Belgian population study. Blood Press Monit 1996; 1: 13-26.
20. Kleinbaum DG, Kupper LL, Muller KE. Applied Regression Analysis and Other Multivariate Methods. PWS-Kent Publishing Company: Boston, MA, USA, 1988, pp 41-79.
21. Wing RR et al. Weight gain at the time of menopause. Arch Intern Med 1991; 151: 97-102.
22. Taylor RD, Corcoron AC, Page IH. Menopausal hypertension: a critical study. Am J Med Sci 1947; 213: 475-476.
23. Sassano P, Chatellier G, Corvol P, Ménard J. Influence of observer's expectation on the placebo effect in blood pressure trials. Curr Ther Res 1987; 41: 305-312.
24. Conway J et al. The use of ambulatory blood pressure monitoring to improve the accuracy and to reduce the number of subjects in clinical trials of antihypertensive agents. J Hypertens 1988; 6: 111-116.
25. Mancia G et al. Effects of blood pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 1983; ii: 695-698.
26. Reneman RS et al. Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol 1986; 12: 465-471.
27. Andersson SG, Hacksaw BT, Still GJ, Greiss FC. Uterine blood flow and its distribution after chronic estrogen and progesterone administration. Am J Obstet Gynecol 1977; 127: 138-142.
28. Wolinsky H. Effects of estrogen and progestogen treatment on the response of the aorta of male rats to hypertension. Circulation 1972; 30: 341-349.
29. Gangar KF et al. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839-842.
30. Sudhir K, Jennings GL, Funder JW, Komesaroff PA. Estrogen enhances basal nitric oxide release in the forearm vasculature in perimenopausal women. Hypertension 1996; 28: 330-334.
31. Taddei S et al. Menopause is associated with endothelial dysfunction in women. Hypertension 1996; 28: 576-582.
32. Walsh BW et al. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engl J Med 1991; 325: 1196-1204.
33. Sack MN, Rader DJ, Cannon ROI. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269-270.
34. Witteman JCM et al. Increased risk of atherosclerosis in women after the menopause. Br Med J 1989; 298: 642-644.
35. van der Schouw YT et al. Age at menopause as a risk factor for cardiovascular mortality. Lancet 1996; 347: 714-717.